Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

Clinical trial NCT06934447 · RECRUITING

Trial details

NCT number: NCT06934447
Sponsor: The Children's Hospital of Zhejiang University School of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CAR T Cell Therapy Systemic Lupus Erythematosus BCMA

Start date: 2025-04-25
Primary completion: 2028-04-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.